Roberto Gradnik
Fondatore presso IXALTIS SAS
Provenienza dei contatti di primo grado di Roberto Gradnik
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Zambon SpA
 Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
IXALTIS SAS
 IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.
12
| Holding Company | Pharmaceuticals: Major | 12 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.
9
| Subsidiary | Medical Specialties | 9 |
| Subsidiary | Pharmaceuticals: Major | 7 | |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Stallergenes Italia Srl
 Stallergenes Italia Srl Medical DistributorsDistribution Services Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The company has a deep understanding of allergens and is committed to innovation.
2
| Subsidiary | Medical Distributors | 2 |
Stallergenes, Inc.
1
| Subsidiary | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Roberto Gradnik tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Miscellaneous Commercial Services | Director/Board Member | |
IRDI Capital Investissement SAS
 IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Sofimac Innovation SAS
 Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Director/Board Member Private Equity Investor | |
| INSEAD | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree | |
| University of Bocconi | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
IXO Private Equity SAS
 IXO Private Equity SAS Investment ManagersFinance IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks. | Investment Managers | Private Equity Investor Private Equity Investor | |
Gefim SpA
 Gefim SpA Real Estate Investment TrustsFinance GEFIM SpA provides real estate investment and management services. The firm specializes in development, rehabilitation, and management of industrial spaces within urban cities and metropolitan areas. Its focuses on areas encompass project financing, economic feasibility studies, financial planning, administrative and technical support, and property acquisition. It also engages in contracting operations, focuses on the construction and design of industrial buildings and facilities. The company was founded by Cavaliere Paolo Ponchia in 1880 and is headquartered in Turin, Italy. | Real Estate Investment Trusts | Corporate Officer/Principal Director/Board Member | |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Secofind SIM SpA
 Secofind SIM SpA Financial ConglomeratesFinance Secofind SIM SpA engages in the provision of investment services. It offers wealth protection, optimization, and management. The company was founded in 2000 and is headquartered in Milan, Italy. | Financial Conglomerates | Chairman Director/Board Member | |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Cleops SRL
 Cleops SRL Financial ConglomeratesFinance Part of Gefim SpA, Cleops SRL is an investment holding Italian company. The company is based in Milan, Italy. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Enaz Srl
 Enaz Srl Financial ConglomeratesFinance Enaz Srl functions as an investment holding Italian company. The private company is based in Milan, Italy. | Financial Conglomerates | President Director/Board Member | |
| Zeta4 Srl | Corporate Officer/Principal Director/Board Member | ||
Itaz Srl
 Itaz Srl Financial ConglomeratesFinance Itaz Srl is an investment holding Italian company. The private company is based in Milan, Italy. | Financial Conglomerates | Director/Board Member Chairman | |
Iava Srl
 Iava Srl Financial ConglomeratesFinance Iava Srl is an investment holding Italian company. The private company is based in Milan, Italy. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Stallergenes Ibérica SA | Chairman Director/Board Member | ||
Zambon Group SpA
 Zambon Group SpA Pharmaceuticals: MajorHealth Technology Zambon Group SpA engages in the production of chemicals and medicines. The company was founded in 1906 and is headquartered in Bresso, Italy. | Pharmaceuticals: Major | Chairman Chairman | |
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Director/Board Member Chairman | |
Stallergenes Belgium SA
 Stallergenes Belgium SA Pharmaceuticals: MajorHealth Technology Stallergènes Belgium NV manufactures pharmaceutical products used for the treatment of allergies. It produces desensitization products and treatment for allergies. The firm has offices in Belgium, Czech Republic, Germany, Spain, France, Italy, the Netherlands, Austria, Poland, Portugal, and Slovenia. The company was founded in 1962 and is headquartered in Waterloo, Belgium. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Ventac Partners LLC | Founder | ||
Stallergenes AG
 Stallergenes AG Pharmaceuticals: OtherHealth Technology Stallergenes AG engages in the manufacture and distribution of products in the medical, diagnostic, and cosmetic fields. It specializes in the production of allergen extracts for allergen immunotherapy. The firm also offers tools for the diagnosis of allergies. The company was founded on October 28, 1996 and is headquartered in Dietlikon, Switzerland. | Pharmaceuticals: Other | Chairman Chairman | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Farmindustria
 Farmindustria Miscellaneous Commercial ServicesCommercial Services Farmindustria is an association of pharmaceutical companies that are based in Italy. The private company provides an interactive map that shows the location of their offices, production sites, and research centers. Farmindustria is located in Rome, Italy. The Italian company promotes the value of the pharmaceutical industry in terms of employment, investment, innovation, research and development, production, and export. The company also provides updates on COVID-19 and information on the pharmaceutical industry. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Fondazione Zoé - Zambon Open Education | President Director/Board Member | ||
| Angama SRL | Director/Board Member Director/Board Member | ||
FineHeart SA
 FineHeart SA Pharmaceuticals: MajorHealth Technology FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Healthneed AB | Director/Board Member | ||
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director of Finance/CFO | |
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Orbit Genomics, Inc.
 Orbit Genomics, Inc. Packaged SoftwareTechnology Services Orbit Genomics, Inc. operates as a technology platform for early disease detection, treatment, and prevention of diseases. The company is based in Boulder, CO. The company was founded by Elizabeth Willis, Harold Garner. Elizabeth Willis has been the CEO since incorporation. | Packaged Software | Chairman | |
| Geleven SRL | Chief Executive Officer | ||
Priothera Ltd.
 Priothera Ltd. BiotechnologyHealth Technology Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland. | Biotechnology | Director/Board Member | |
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
Mahzi Therapeutics, Inc.
 Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Reaction Capital
 Reaction Capital Investment ManagersFinance Reaction Capital (Reaction) is a venture capital firm founded in 2019. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Zambon Company SpA
 Zambon Company SpA Pharmaceuticals: MajorHealth Technology Zambon Co. SpA operates as an industrial holding company with interests in pharmaceuticals and chemicals. The company was founded by Gaetano Zambon on November 11, 1906 and is headquartered in Bresso, Italy. | Pharmaceuticals: Major | Director/Board Member President Chief Executive Officer | |
Zambon Immobiliare SpA
 Zambon Immobiliare SpA Real Estate DevelopmentFinance Part of GEFIM SRL, Zambon Immobiliare SpA is an Italian company that provides real estate services. The company is based in Bresso, Italy. | Real Estate Development | Director/Board Member Director/Board Member | |
| STALLERGENES GREER | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Italia | 19 |
| Stati Uniti | 12 |
| Francia | 8 |
| Svezia | 5 |
| Irlanda | 3 |
Settori
| Health Technology | 25 |
| Finance | 12 |
| Consumer Services | 4 |
| Commercial Services | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 269 |
| Chairman | 80 |
| Corporate Officer/Principal | 76 |
| Chief Executive Officer | 39 |
| Independent Dir/Board Member | 32 |
Contatti più connessi
| Insiders | |
|---|---|
| Stefan Mario Meister | 57 |
| François Miceli | 43 |
| Elena Zambon | 36 |
| Elmar Schnee | 31 |
| Giovanni Cagnoli | 28 |
| Jean-Michel Petit | 24 |
| Massimo Tononi | 24 |
| Margherita Zambon | 23 |
| Marten Steen | 21 |
| Christian Chavy | 18 |
| Mikael Oerum | 17 |
| Guido Guidi | 17 |
| Lena Elisabeth Svanberg | 16 |
| Giacomo di Nepi | 16 |
| Albert Saporta | 15 |
- Borsa valori
- Insiders
- Roberto Gradnik
- Connessioni Società